Equity
€14,725 from €101,587 in 2023
Equity fell by 86% in 2 years.
CUORE
Lifetime
5 annual accounts with figures on one time axispeak €671,633 (2024)
-€3,831▼ €675,464
lowest -€24,252 (2022)
-€7,716▼ €503,570
peak €101,587 (2023)
€14,725▼ 34.4%
€16,119▼ 97.4%
Board1 name since 2019
1 directorKEYMIS Michel
Documentsfilings and deeds
10-02-202610 days late
2025abbreviated format
Gross margin from €671,633 to -€3,831Loss of €7,716Equity from €22,441 to €14,725Debts from €626,616 to €16,119Cash from €79,497 to €21,580
Key points
from the 2025 annual accountsResult
-€7,716 -€7,716
From profit to loss in 2025, after a profit of €495,854 in 2024.
Liquidity
1.90 was 1.03 in 2024
Short-term debts fell from €626,616 to €16,119.
Filings
5 annual accounts 1 late
The 2025 accounts came 10 days late. The other four were filed on time.
Starting capital
€20,000 200 shares
Position in the sector
-€7,716
Lower net result than 91% of companies in human health. Sector median €110,061 · 3,019 companies.
Turnover not published (abbreviated format)
Checked score
91
Excellent
Financially stronger than 28% of micro companies in human health (NACE 86)
Probability in this band: under 0.55%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%
The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).
Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
12-2024: 0.1%
01-2025: < 0.1%▼ -0.1 percentage points vs 12-2024
02-2025: < 0.1%● unchanged vs 01-2025
03-2025: < 0.1%● unchanged vs 02-2025
04-2025: < 0.1%● unchanged vs 03-2025
05-2025: < 0.1%● unchanged vs 04-2025
06-2025: < 0.1%● unchanged vs 05-2025
07-2025: < 0.1%● unchanged vs 06-2025
08-2025: < 0.1%● unchanged vs 07-2025
09-2025: 0.1%▲ +0.1 percentage points vs 08-2025
10-2025: 0.1%● unchanged vs 09-2025
11-2025: 0.1%● unchanged vs 10-2025
12-2025: 0.1%● unchanged vs 11-2025
01-2026: 0.1%● unchanged vs 12-2025
02-2026: 0.2%▲ +0.1 percentage points vs 01-2026highest value
03-2026: < 0.1%▼ -0.2 percentage points vs 02-2026
04-2026: < 0.1%● unchanged vs 03-2026
05-2026: < 0.1%● unchanged vs 04-2026
06-2026: < 0.1%● unchanged vs 05-2026
07-2026: < 0.1%● unchanged vs 06-2026
08-2026: < 0.1%● unchanged vs 07-2026lowest value
09-2026: < 0.1%● unchanged vs 08-2026
10-2026: < 0.1%● unchanged vs 09-2026
11-2026: < 0.1%● unchanged vs 10-2026
Financial strengthAverage
Score breakdown
raises risk
Loss of €7,716 (financial year 2025)
lowers risk
Sector: Human health activities (NACE 86)
Liquidity: current ratio 1.90, cash €21,580, halved
Size: total assets €30,844
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 38% of them on solvency, 55% on liquidity, 1% on profitability and 16% on growth.
The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 30-06-2025.
Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Comparable companies, two years later
In July 2024, 3,591 companies had the same profile as CUORE has now. Each dot stands for 9 companies, two years later.
87.3%
were still trading
9.4%
stopped another way
3.0%
went bankrupt
Another 0.3% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of CUORE itself is lower: < 0.1% within 12 months. It rests on far more data about CUORE than the profile alone.
Test of the method
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 3,591 companies, not a prediction for CUORE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit of up to €1,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 1.9 (1.03 in 2024), above the usual 1.5. Short-term debt is 52.3% and cash 70% of total assets. However, 52.3% of the assets are financed with debt and provisions.
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Five signals.
lowers riskraises riskneutral
neutral · A punctual record breaks
This company filed 4 consecutive financial years on time. The year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 10-02-2026, 10 days late. Weigh it accordingly: of the companies that move to filing 1 to 90 days late, 1.41% are now bankrupt, dissolved or in another special legal status, below the 1.66% of all filers. It is a change in behaviour, not evidence of elevated risk.
NBB · 5 filingsDeviation from the deadline
2025
10 days late
2024
50 days early
2023
on the day
2022
on the day
2021
4 days early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
The company filed its last 5 accounts on average 9 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The financial year that closed on 30-06-2026 is due by 31-01-2027. Nothing is late today. The company usually files around 31 January (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven monthsWhere today falls in the filing period
30-06-2026 year end10-11-2026 today31-01-2027 deadline
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0734974344
Amendment of the articles
“Het verstrekken van diensten in verband met alle klassieke kinesitherapeutische behandelingstechnieken,manuele…” (deed in Dutch) · Gazette deed
Environmental permit granted
Bouwen of herbouwen · Knokke-Heist
First establishment
Meidoornlaan 15, Knokke-Heist
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| CUORE Knokke-Heist | €30,844 | -€3,831 | 47.7% | - |
| Maxime CROSSET - Kinésithérapie Malmedy | €25,999 | €736 | 76.0% | - |
| EN MAUD COULEURS Comblain-au-Pont | €40,828 | -€531 | 40.6% | - |
| Instituut voor Orale en MaxilloFaciale Chirurgie Onderwijs en Training Tielt-Winge | €50,102 | -€159,197 | -30.2% | - |
| BEODIS Lier | €34,813 | -€2,785 | 53.1% | - |
| Baronaut Antwerp | €16,491 | -€246 | 94.6% | - |
| STUDIO DE BOVENKAMER Ghent | €40,093 | €1,652 | 64.2% | - |
These companies have the same main activity as CUORE: nutrition and dietetics services (NACE 86995). They are comparable in size and age: total assets between €16,500 and €50,100, founded between 2015 and 2021.
Official details
Source: KBO- Status
- Active since 26-09-2019Normal situation
- Activity
- Nutrition and dietetics servicesNACE 86995and 2 others
- Establishment unit
- 2.293.904.2038300 Knokke-Heist, since 01-10-2019
- Financial year end
- 30 June
- Peppol
- Reachable since 28-11-2025
Insights on CUORE
CUORE files the abbreviated format. That format states no turnover. The gross margin rose from -€14,892 in 2021 to -€3,831 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about CUORE
- What is the company number of CUORE?
- The company number of CUORE is 0734.974.344. The VAT number is the same number with BE in front: BE 0734.974.344.
- Where is CUORE based?
- The registered office is at Meidoornlaan 15, 8300 Knokke-Heist.Company details
- What does CUORE do?
- According to the KBO register, the main activity is nutrition and dietetics services (NACE 86995).
- What is the legal form of CUORE?
- CUORE is a private limited company (BV).
- When was CUORE founded?
- CUORE was founded on 26-09-2019.
- Is CUORE still active?
- Yes, CUORE is an active enterprise in the KBO register.
- What is the turnover of CUORE?
- The annual accounts for financial year 2025 state no turnover. The abbreviated format does not require it.Financials
- Is CUORE profitable?
- In financial year 2025, CUORE made a loss of €7,716.
- Where can I find the annual accounts of CUORE?
- CUORE filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of CUORE due?
- CUORE must file the annual accounts for financial year 2026 by 31-01-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.